Accès gratuit
Numéro
Radioprotection
Volume 59, Numéro 2, April - June
Page(s) 131 - 137
DOI https://doi.org/10.1051/radiopro/2024008
Publié en ligne 3 juin 2024

© SFRP, 2024

1 Introduction

COVID-19, caused by the SARS-CoV-2 virus, initially emerged as a respiratory illness primarily affecting adults, but it has also been observed in pediatric populations (Zimmermann and Curtis, 2020). Although children generally experience milder symptoms compared to adults, severe cases and complications, including Multisystem Inflammatory Syndrome in Children (MIS-C), have been reported (Hennon et al., 2020). Studies have shown that children can contract and transmit the virus, even if they are often asymptomatic or exhibit mild symptoms (Adeyinka et al., 2021). It is crucial to closely monitor and understand the impact of COVID-19 on pediatric patients to guide appropriate public health measures and medical interventions (Howard‐Jones et al., 2022).

Computed Tomography (CT) scans have become an indispensable tool in pediatric diagnostic imaging due to their ability to provide detailed cross-sectional images of the body (Hussain et al., 2022). CT scans offer valuable information for the evaluation of various conditions in children, including trauma, neurological disorders, pulmonary diseases, abdominal pathologies, and recently COVID-19 diagnosis (Biagas et al., 2019; Kaufman et al., 2020; Li et al., 2020; Lin and Lin, 2016).

However, it is important to use CT scans judiciously in pediatric patients due to the potential risks associated with ionizing radiation exposure (Garg et al., 2021). The use of CT scans in pediatric patients is associated with potential long-term risks, particularly in terms of radiation-induced cancer (Marcu et al., 2021).

Ionizing radiation from diagnostic imaging, including CT scans, has been found to increase the lifetime risk of cancer (Garg et al., 2021; Marcu et al., 2021). Several studies have investigated this risk, emphasizing the importance of minimizing radiation exposure in children (Berrington de Gonzalez et al., 2021). A population-based cohort study by Mathews et al. found that pediatric patients who underwent CT scans had a small but statistically significant increase in their risk of developing solid cancers later in life (Mathews et al., 2013). Another study by Pearce et al. estimated that exposure to radiation from two to three CT scans in childhood might lead to a doubling of the risk of leukemia (Pearce et al., 2012). Also, Meulepas et al. conducted a retrospective cohort study on 168,394 children nationwide and discovered a link between exposure to radiation from CT scans and an elevated risk of brain tumors (Meulepas et al., 2019).

Given these findings, it is crucial to adopt radiation dose reduction techniques and follow evidence-based imaging guidelines to minimize unnecessary radiation exposure and ensure the clinical benefits of CT scans outweigh the associated cancer risks in pediatric populations.

During the COVID-19 pandemic, our hospital faced a large number of CT scans for the diagnosis, screening, and monitoring of COVID-19 paediatric patients. In order to reduce paediatric radiation dose, we implemented a new chest CT protocol called COVID-19 Diagnosis CT protocol (CD-CT).

The objective of this study is to compare the radiation dose and the risk of cancer incidence associated with ionizing radiation in two chest CT protocols: namely, the routine chest CT (RC-CT) protocol and the CD-CT protocol.

2 Materials and methods

The study received approval from our institution’s ethics committee, and obtaining consent forms was not deemed necessary. This retrospective study recorded a total of 254 patients who underwent a chest CT examination with RC-CT protocol or CD-CT protocol from March 2020 to May 2022. The patients were divided into three age groups: G1 (<5), G2 (5–<10), and G3 (10–15). It should be noted that the CD-CT protocol was chosen for patients undergoing COVID-19 diagnosis, while the RC-CT protocol was used for other patients with the indications of mainly evaluation of infectious and lung diseases. Patient’s demographic data were acquired through the picture archiving and communication system (PACS). The matching between the two groups (CD-CT protocol and RC-CT protocol for males and females separately) was conducted based on an equal number of patients and effective diameter. The patient selection between the two groups was carried out in a way to match the effective diameter in the two groups.

To calculate the effective diameter of the chest, the middle slice of the scanning region was used and the anterior-posterior (AP) and lateral (L) distances were measured. The equation recommended by AAPM 204 was then used to calculate the effective diameter (Medicine, 2011) as follow;

effective diameter = A P × L

2.1 Collection of CT dose parameters

All patients were imaged with a 16 slice CT scanner (Somatom Emotion, Siemens, Germany). The chest CT scanning range was set using a scout view from the lung apices to the lung bases. Table 1 shows CT scanning parameters of two protocols for three age groups. Slice thickness and nominal beam width were constant for all groups. Three tube potentials (kVp) were used: 80, 110, and 130, manually based on the CT technologist’s experience. Lower tube current (mAs) was used for CD-CT protocol, and the CareDose 4D option was activated for all patients during CT scanning. All the radiologists working at our institution have approved the image quality of both protocols based on the assessment of image noise in the CTDI phantom.

The values of volumetric CT dose index (CTDIvol), dose length product (DLP) and the parameters of two chest CT protocols were extracted from dose report page by looking back at the PACS.

In this study also size specific dose estimate (SSDE) was calculated by multiplying CTDIvol and a conversion factor provided in AAPM 204 report. The SSDE is a more accurate radiation dose metric for patients of different sizes compared to the CTDIvol alone, as it takes into account the patient’s size, which can affect the effective dose received during the CT scan.

Table 1

CT scanning parameters of two protocols for three age groups.

2.2 Estimation of organ dose and effective dose

Organ doses (mSv) and effective dose (mSv) were estimated using the National Cancer Institute dosimetry system for CT (NCICT) software version 3.0 (Lee et al., 2015). Organ doses were calculated for organs in the field of scanning range such as thyroid, esophagus, lung, breast and stomach by employing a Monte Carlo simulation and an International Commission on Radiological Protection (ICRP) standard pediatric phantom (Lee et al., 2015).

2.3 Estimation of cancer incidence risk

Estimation of cancer incidence risks were conducted according to the Biological Effects of Ionizing Radiation (BEIR) VII report (Council, 2006). The models presented in the BEIR VII report take into account a range of factors that can influence the risk of cancer, the age and gender of the exposed individual, and the dose. The report also provides estimates of the risks associated with different types of cancer, including solid tumors and leukemia.

Cancer risks were calculated for different organs, including thyroid, lung, and breast.

2.4 Statistical analysis

The statistical analysis was performed using SPSS software (version 23), with mean and standard deviation (SD) used to express all values. Furthermore, the Mann–Whitney test was employed to compare the means of continuous variables between the two groups due to the non-normality of the data, as assessed by the Kolmogorov–Smirnov test. Statistical significance was interpreted as differences with a p-value less than 0.05.

3 Results

Table 2 shows demographic data and values of effective diameter for the two groups of the patients. The number of patients in the two protocols according to gender was equal to facilitate a better matching process. The age of patients ranged from 2.7 ± 0.9 years in the male CD-CT protocol group to 13.0 ± 1.7 years in the female CD-CT protocol group. There were no statistical differences in terms of effective diameter between the two protocols for all age groups (P > 0.05).

Data on dose descriptors such as CTDIvol, DLP, effective dose and SSDE are summarized in Table 3. The lowest values of CTDIvol were 2.4 ± 0.6 mGy and 1.1 ± 0.4 mGy for RC-CT and CD-CT protocols in the G1 group, respectively. The highest values of CTDIvol were 3.3 ± 0.9 mGy and 1.5 ± 0.3 mGy for RC-CT and CD-CT protocols in the G3 group, respectively.

The lowest values of DLP (mGy.cm) were 58.7 ± 14.3 and 26.7 ± 12.2 for RC-CT and CD-CT protocols in the G1 group, respectively. The highest values of DLP (mGy.cm) were 87.1 ± 15.3 and 39.6 ± 12.7 for RC-CT and CD-CT protocols in the G3 group, respectively.

The lowest values of effective dose were 1.4 ± 0.6 mSv and 0.9 ± 0.2 mSv for RC-CT and CD-CT protocols in the G1 group, respectively. The highest values of effective dose were 1.9 ± 2.3 mSv and 1.2 ± 0.3 mSv for RC-CT and CD-CT protocols in the G3 group, respectively.

The lowest values of SSDE were 4.5 ± 1.2 mGy and 2.1 ± 0.5 mGy for RC-CT and CD-CT protocols in the G1 group, respectively. The highest values of SSDE were 5.7 ± 2.1 mGy and 2.6 ± 0.5 mGy for RC-CT and CD-CT protocols in the G3 group, respectively. The statistical analysis showed that the SSDE was lower in the CD-CT protocol group compared to the RC-CT protocol group for all three age groups (P < 0.05).

Figure 1 presents organ doses for G1, G2, and G3. For the males, the lungs received the highest organ dose (4.27 ± 1.4 mGy) in the RC-CT protocol of the G3 age group. Also, for the females, the lungs received the highest organ dose (3.90 ± 1.23 mGy) in the RC-CT protocol of the G3 age group.

For the breast in females, the highest dose (3.17 ± 0.99 mGy) was in the RC-CT protocol of the G3 age group, and the lowest dose (1.96 ± 0.52 mGy) was in the CD-CT protocol of the G1 age group. It should be noted that for all three age groups and for males and females, CD-CT groups received statistically lower organ dose (P < 0.05).

Figure 2 shows cancer incidence risk of some organs for G1, G2, and G3. Among the three age groups, the risk of cancer incidence of thyroid, lung, and breast was higher for the G1 age group. The risk of breast cancer incidence was highest (19.66 ± 6.14) in the females RC-CT of G1 age group and lowest (10.66 ± 2.71) in the females CD-CT of G3 age group. The risk of lung cancer incidence was highest (16.41 ± 4.92) in the females RC-CT of G1 age group and lowest (8.83 ± 2.36) in the females CD-CT of G3 age group. The lowest cancer risk was for thyroid in all three age groups for males and females.

It should be noted that for all three age groups and for males and females, CD-CT groups had statistically lower risk of cancer incidence (P < 0.05).

Table 2

Demographic data and values of effective diameter.

Table 3

Data on CTDIvol, DLP, effective dose and SSDE.

thumbnail Figure 1

Organ dose of different organs for three age groups.

thumbnail Figure 2

Cancer incidence risk (per 100,000 individuals) of different organs for three age groups.

4 Discussion

Several studies emphasize the importance of minimizing radiation dose in children undergoing CT scans, particularly by employing pediatric-specific imaging protocols and dose reduction techniques (Miglioretti et al., 2013). Adhering to these guidelines helps to strike a balance between diagnostic accuracy and reducing radiation-related risks in the pediatric population. In this study, we compared the organ dose and cancer risk associated with RC-CT and CD-CT protocols that were implemented in our institution.

Based on Table 2, the p-values related to effective diameter for the comparison of the two protocols for all age groups was above 0.05, indicating a good match between the two protocols. In other study (Bagherzadeh et al., 2021), body mass index (BMI) was used to match two groups. However, in this study, we did not have access to BMI data, so we could not use it for matching. Instead, the matching between the two groups (CD-CT protocol and RC-CT protocol for males and females separately) was conducted based on an equal number of patients and effective diameter. As expected, the maximum effective diameter was for the oldest group, which is in line with the study by Karim et al. (2021) study. This is because effective diameter is a measure of the size of the body part being imaged, and older individuals tend to have larger body parts due to factors such as growth, and weight gain. Other factors such as gender and anatomical region can also affect effective diameter, as can be seen from Table 1, where it is shown that the effective diameter of males is slightly higher than that of females, which is in line with the study by Franck et al. (2016) and Karim et al. (2021).

It can be observed that the tube current utilized for CD-CT was lower than that used for RC-CT. The use of a lower tube current can help to reduce the radiation dose to the patient, while the CareDose 4D option can further optimize the radiation dose based on the patient’s size and shape. These techniques are in line with current best practices for radiation dose reduction in medical imaging, which aim to balance the need for high-quality diagnostic images with the need to minimize potential risks associated with radiation exposure (Wang et al., 2019).

It was also observed that a higher pitch factor was utilized for the younger age group, which can help to reduce the radiation dose to the patient (Kalra et al., 2020).

All dose descriptors had lowest values for youngest age group (G1) and highest values for oldest age group (G3). Also, Karim et al. (2021), Gao et al. (2018), Galanski et al. (2005), and Mohammadbeigi et al. (2019) reported that CTDIvol and DLP had lowest values in youngest pediatric group and highest values in oldest pediatric group. In Admontree et al. (2019) study, the oldest age group did not have the highest values of CTDIvol. Instead, they found that the highest CTDIvol value was observed in group 2 (5–<10). The CTDIvol and DLP measured in this study did not exceed the reference levels reported in literature surveys on paediatric CT chest radiation dose for all age groups (Gao et al., 2018; Radiology, 2016; Shrimpton et al., 2006; Verdun et al., 2008).

The calculation of SSDE in this study also took into account the patient’s effective diameter as a crucial factor in estimating the absorbed dose during the CT scan. By considering the effective diameter, which represents the average cross-sectional dimension of the patient, the SSDE calculation provides a more accurate estimation of the absorbed dose specific to the patient undergoing the CT scan. The mean values of SSDE (mGy) in the CD-CT protocol group were 2.1 ± 0.5, 2.5 ± 0.6, and 2.6 ± 0.5 for G1, G2, and G3, respectively. Also, the corresponding values in the RC-CT protocol group were 4.5 ± 1.2, 5.5 ± 1.2, and 5.7 ± 2.1 for G1, G2, and G3, respectively. These findings show that the radiation doses in terms of SSDE were statistically lower in the CD-CT protocol group compared to the RC-CT protocol group for all three age groups. Specifically, the mean SSDE values in the CD-CT group were roughly half of those observed in the RC-CT group for each age group. These results demonstrate that the choice of CT protocol can significantly impact the radiation dose received by pediatric patients during CT imaging, highlighting the importance of carefully selecting the appropriate protocol to minimize radiation exposure.

The SSDE values for the two chest CT protocols used in our study’s G1 age group were lower than those reported in previous studies by Karim et al. (4.6 mGy), Admontree et al. (5.2 mGy) and Mohammadbeigi et al. (7.4 mGy). Similarly, the SSDE values for the two chest CT protocols used in our study’s G2 age group were lower than those reported in previous studies by Karim et al. (6.7 mGy), Admontree et al. (6.1 mGy), Mohammadbeigi et al. (11.1 mGy), and Strauss et al. (5.1 mGy). Additionally, the SSDE values for the two chest CT protocols used in our study’s G3 age group were lower than those reported in previous studies by Karim et al. (7.6 mGy), Admontree et al. (6.3 mGy), Mohammadbeigi et al. (10.4 mGy), and Strauss et al. (6.6 mGy).

The results of the organ dose analysis in chest CT imaging revealed that the lung received the highest radiation dose, followed by the esophagus, breast, thyroid, and stomach. These results are consistent with the study by Karim et al. (2021), with the exception that they reported a higher radiation dose to the breast than to the thyroid gland, which may be related to difference in setting the upper border of scanning range. Therefore, exact setting of the scanning range during chest CT scanning may be necessary to reduce the radiation dose to the thyroid. It is worth noting that they also used the NCICT software to calculate the organ doses. In line with previous comparison studies (Karim et al., 2021), our results showed a pattern of increasing organ doses with age, with the lowest values observed in the youngest age group and a gradual increase in doses with increasing age. The results of the organ dose analysis in our study were lower than those reported in other comparable studies (Giansante et al., 2019; Karim et al., 2021).The organ doses in CD-CT protocol are significantly lower than the RC-CT protocol, indicating that the use of CD-CT protocol may be a more favorable option for reducing radiation exposure in pediatric patients undergoing CT imaging.

The most current researches suggest compelling evidence linking the occurrence of cancer to low-level radiation exposure from CT examinations (Alkhorayef, 2018; Hong et al., 2019). The results of the cancer incidence risk analysis indicated that the lung had the highest risk for males, while the breast had the highest risk for females across all age groups. Even though the lung received the highest radiation dose in females, the breast had a higher cancer risk than the lung across all age groups, which is in line with Tahmasebzadeh et al. (2021) study. This is because, according to Table 12D-1 in the BEIR VII report, the breast has a higher cancer risk than the lung up to 20 years of age.

Furthermore, the results showed that the incidence risk of thyroid and lung cancer is higher in females than in males. According to Table 12D-1 in the BEIR VII report, females have a higher cancer risk than males for both types of cancer across all age groups.

In contrast to our findings, Karim et al. (2021) reported the highest cancer risk in the thyroid for females. This may be related to the different used reports for estimating cancer risk, where they utilized ICRP 103 publication report. Based on the ICRP 103 publication report, the nominal risk coefficient value was zero for the esophagus and breast in children aged between 0 and 15 years, and thyroid have highest risk value.

Our study, as depicted in Figure 2, revealed a decreasing trend in cancer risk with increasing age, which is in line with Tahmasebzadeh et al. (2021) study. However, this trend is not in agreement with the findings of Karim et al. (2021). This difference may be attributed to the use of different reports for estimating cancer risk in the two studies.

Moreover, the cancer incidence risks per 100,000 individuals in this study were higher than those reported by Karim et al. (2021). However, the SSDE values in their study were higher than those in this study. This may be related to the fact that the BEIR VII report used in this study for estimating cancer risk represents a conservative approach to estimating radiation risks.

The cancer risks associated with the CD-CT protocol are significantly lower than those of the RC-CT protocol, suggesting that the use of CD-CT protocol may be a safer and more effective option for reducing radiation exposure in pediatric patients undergoing CT imaging.

According to the provided CT scan parameters and results, it can be proposed to optimize the radiation dose by reducing the tube current-time product. One limitation of this study is presenting radiation dose results without providing image quality parameters, which should be addressed in future studies.

5 Conclusion

The study found that the CD-CT protocol resulted in lower cancer risks and organ doses. It can be concluded that the choice of CT protocol can significantly impact the radiation dose received by pediatric patients during CT imaging, highlighting the importance of carefully selecting the appropriate protocol to minimize radiation exposure. Overall, the findings suggest that the use of pediatric-specific imaging protocols such as CD-CT protocol and dose reduction techniques, can be a more favorable option for reducing radiation exposure in pediatric patients undergoing CT imaging.

Acknowledgements

The author of this research would like to express his appreciation to the medical imaging Unit of Allameh Bohlool Gonabadi Hospital.

Funding

The Gonabad university of medical sciences provided funding for this project (grant number: 1293).

Conflicts of Interest

There is no conflict of interest.

Data availability statement

The data that support the findings of this study are available on request from the corresponding author.

Ethics approval

The study received ethical approval from ethics committee of Gonabad University of Medical Sciences.

Informed consent

Informed consent was not deemed necessary for this study.

References

  • Adeyinka A, Bailey K, Pierre L, Kondamudi N. 2021. COVID 19 infection: pediatric perspectives. J Am College Emerg Phys Open 2 (1): e12375. [CrossRef] [Google Scholar]
  • Admontree S, Junsorn S, Tathip R, Todsatidpaisan S, Buachan P, Asavaphatiboon S. 2019. Evaluation of Size-Specific Dose Estimates (SSDE) in paediatric body imaging using 320-detector CT. Naresuan Univ J: Sci Technol 27 (2): 28–35. [Google Scholar]
  • Alkhorayef M. 2018. Radiation risk from chest, abdomen and pelvis computed tomography investigations. J Radioanal Nucl Chem 318 (1): 661–665. [CrossRef] [Google Scholar]
  • Bagherzadeh S, Jabbari N, Khalkhali HR. 2021. Radiation dose and cancer risks from radiation exposure during abdominopelvic computed tomography (CT) scans: comparison of diagnostic and radiotherapy treatment planning CT scans. Radiat Environ Biophys 60: 579–589. [CrossRef] [PubMed] [Google Scholar]
  • Berrington de Gonzalez A, Pasqual E, Veiga L. 2021. Epidemiological studies of CT scans and cancer risk: the state of the science. Br J Radiol 94: 20210471. [CrossRef] [PubMed] [Google Scholar]
  • Biagas KV, Gross ER, Muratore CS. 2019. Evaluation of the pediatric trauma patient: support for judicious use of CT imaging. Pediatric Crit Care Med 20 (6): 579–580. [CrossRef] [PubMed] [Google Scholar]
  • Council NR. 2006. Health risks from exposure to low levels of ionizing radiation: BEIR VII phase 2. [Google Scholar]
  • Franck C, Vandevoorde C, Goethals I, Smeets P, Achten E, Verstraete K, et al. 2016. The role of Size-Specific Dose Estimate (SSDE) in patient-specific organ dose and cancer risk estimation in paediatric chest and abdominopelvic CT examinations. Eur Radiol 26: 2646–2655. [CrossRef] [PubMed] [Google Scholar]
  • Galanski M, Nagel H, Stamm G. 2005. Paediatric CT exposure practice in the Federal Republic of Germany. Results of a nation-wide survey in, 6: 2006. [Google Scholar]
  • Gao Y, Quinn B, Pandit-Taskar N, Behr G, Mahmood U, Long D, et al. 2018. Patient-specific organ and effective dose estimates in pediatric oncology computed tomography. Phys Med 45: 146–155. [CrossRef] [PubMed] [Google Scholar]
  • Garg M, Prabhakar N, Bhalla AS. 2021. Cancer risk of CT scan in COVID-19: resolving the dilemma. Indian J Med Res 153 (5-6): 568. [CrossRef] [PubMed] [Google Scholar]
  • Giansante L, Martins JC, Nersissian DY, Kiers KC, Kay FU, Sawamura MV, et al. 2019. Organ doses evaluation for chest computed tomography procedures with TL dosimeters: comparison with Monte Carlo simulations. J Appl Clin Med Phys 20 (1): 308–320. [CrossRef] [PubMed] [Google Scholar]
  • Hennon TR, Penque MD, Abdul-Aziz R, Alibrahim OS, McGreevy MB, Prout AJ, et al. 2020. COVID-19 associated multisystem inflammatory syndrome in children (MIS-C) guidelines; a Western New York approach (Vol. 57, pp. 101232): Elsevier. [Google Scholar]
  • Hong J-Y., Han K, Jung J-H., Kim JS. 2019. Association of exposure to diagnostic low-dose ionizing radiation with risk of cancer among youths in South Korea. JAMA Network Open 2 (9): e1910584–e1910584. [CrossRef] [PubMed] [Google Scholar]
  • Howard‐Jones AR, Bowen AC, Danchin M, Koirala A, Sharma K, Yeoh DK, et al. 2022. COVID‐19 in children: I. Epidemiology, prevention and indirect impacts. J Paediatr Child Health 58: 39–45. [CrossRef] [PubMed] [Google Scholar]
  • Hussain S, Mubeen I, Ullah N, Shah SSUD, Khan BA, Zahoor M, Sultan MA. 2022. Modern diagnostic imaging technique applications and risk factors in the medical field: A review. BioMed Research International. [PubMed] [Google Scholar]
  • Kalra MK, Homayounieh F, Arru C, Holmberg O, Vassileva J. 2020. Chest CT practice and protocols for COVID-19 from radiation dose management perspective. Eur Radiol 30: 6554–6560. [CrossRef] [PubMed] [Google Scholar]
  • Karim M, Harun H, Kayun Z, Aljewaw O, Azizan S, Rafiz N, Muhammad N. 2021. Paediatric radiation dose and cancer risk associated with body effective diameter during CT thorax examination. Radiation Phys Chem 188: 109685. [CrossRef] [Google Scholar]
  • Kaufman AE, Naidu S, Ramachandran S, Kaufman DS, Fayad ZA, Mani V. 2020. Review of radiographic findings in COVID-19. World J Radiol 12 (8): 142. [CrossRef] [PubMed] [Google Scholar]
  • Lee C, Kim KP, Bolch WE, Moroz BE, Folio L. 2015. NCICT: a computational solution to estimate organ doses for pediatric and adult patients undergoing CT scans. J Radiolog Prot 35: 891. [CrossRef] [PubMed] [Google Scholar]
  • Li B, Shen J, Li L, Yu C. 2020. Radiographic and clinical features of children with coronavirus disease (COVID-19) pneumonia. Indian Pediatr 57: 423–426. [CrossRef] [PubMed] [Google Scholar]
  • Lin W-C., Lin C-H. 2016. Multidetector computed tomography in the evaluation of pediatric acute abdominal pain in the emergency department. Biomedicine 6: 1–5. [Google Scholar]
  • Marcu LG, Chau M, Bezak E. 2021. How much is too much? Systematic review of cumulative doses from radiological imaging and the risk of cancer in children and young adults. Crit Rev Oncol/Hematol 160: 103292. [CrossRef] [Google Scholar]
  • Mathews JD, Forsythe AV, Brady Z, Butler MW, Goergen SK, Byrnes GB, et al. 2013. Cancer risk in 680 000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ 346. [Google Scholar]
  • Medicine, A.A.O.P.I. 2011. Size-specific dose estimates (SSDE) in pediatric and adult body CT examinations. AAPM Rep 204: 1–30. [Google Scholar]
  • Meulepas JM, Ronckers CM, Smets AM, Nievelstein RA, Gradowska P, Lee C, et al. 2019. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst 111 (3): 256–263. [CrossRef] [PubMed] [Google Scholar]
  • Miglioretti DL, Johnson E, Williams A, Greenlee RT, Weinmann S, Solberg LI, et al. 2013. The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk. JAMA Pediatr 167:, 700–707. [CrossRef] [PubMed] [Google Scholar]
  • Mohammadbeigi A, Khoshgard K, Haghparast A, Eivazi MT. 2019. Local DRLs for paediatric CT examinations based on size-specific dose estimates in Kermanshah, Iran. Radiat Protect Dosimetry 186: 496–506. [CrossRef] [PubMed] [Google Scholar]
  • Pearce MS, Salotti JA, Little MP, McHugh K, Lee C, Kim KP, et al. 2012. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. The Lancet 380: 499–505. [CrossRef] [Google Scholar]
  • Radiology ESO (2016). European guidelines on DRLs for paediatric imaging: PiDRL. [Google Scholar]
  • Shrimpton P, Hillier M, Lewis M, Dunn M. 2003: National survey of doses from CT in the UK. 2006, 79. [Google Scholar]
  • Tahmasebzadeh A, Paydar R, Soltani-Kermanshahi M, Maziar A, Reiazi R 2021. Lifetime attributable cancer risk related to prevalent CT scan procedures in pediatric medical imaging centers. Int J Radiat Biol 97: 1282–1288. [CrossRef] [PubMed] [Google Scholar]
  • Verdun FR, Gutierrez D, Vader JP, Aroua A, Alamo-Maestre LT, et al. 2008. CT radiation dose in children: a survey to establish age-based diagnostic reference levels in Switzerland. Eur Radiol 18: 1980–1986. [CrossRef] [PubMed] [Google Scholar]
  • Wang L, Gong S, Yang J, Zhou J, Xiao J, Gu JH et al. 2019. CARE Dose 4D combined with sinogram‐affirmed iterative reconstruction improved the image quality and reduced the radiation dose in low dose CT of the small intestine. J Appl Clin Med Phys 20: 293–307. [CrossRef] [PubMed] [Google Scholar]
  • Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: an overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children, Pediatr Infect Disease J 39: 355. [Google Scholar]

Cite this article as: Keshtkar M. 2024. Paediatric cancer risks associated with chest computed tomography (CT) scans: comparison of routine chest and COVID-19 diagnosis CT protocols. Radioprotection 59(2): 131–137

All Tables

Table 1

CT scanning parameters of two protocols for three age groups.

Table 2

Demographic data and values of effective diameter.

Table 3

Data on CTDIvol, DLP, effective dose and SSDE.

All Figures

thumbnail Figure 1

Organ dose of different organs for three age groups.

In the text
thumbnail Figure 2

Cancer incidence risk (per 100,000 individuals) of different organs for three age groups.

In the text

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.